MariMed Announces First Quarter 2025 Earnings Date
MariMed (CSE: MRMD, OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, has scheduled its first quarter 2025 earnings release for May 7, 2025 after market close.
The company will host a conference call to discuss the financial results on May 8, 2025 at 8:00 a.m. EDT. Investors can access the webcast through MariMed's Investor Relations website, where a playback will also be available after the call.
MariMed (CSE: MRMD, OTCQX: MRMD), un'azienda leader nel settore dei beni di consumo a base di cannabis e nel commercio al dettaglio, ha programmato la pubblicazione dei risultati finanziari del primo trimestre 2025 per il 7 maggio 2025 dopo la chiusura del mercato.
L'azienda ospiterà una conferenza telefonica per discutere i risultati finanziari l'8 maggio 2025 alle 8:00 EDT. Gli investitori possono accedere al webcast tramite il sito web delle Relazioni con gli Investitori di MariMed, dove sarà disponibile anche una registrazione dopo la chiamata.
MariMed (CSE: MRMD, OTCQX: MRMD), una empresa líder en productos de consumo empaquetados de cannabis y minorista, ha programado la publicación de resultados del primer trimestre de 2025 para el 7 de mayo de 2025 después del cierre del mercado.
La empresa llevará a cabo una conferencia telefónica para discutir los resultados financieros el 8 de mayo de 2025 a las 8:00 a.m. EDT. Los inversores pueden acceder a la transmisión web a través del sitio web de Relaciones con Inversores de MariMed, donde también estará disponible una grabación después de la llamada.
마리메드 (CSE: MRMD, OTCQX: MRMD), 선도적인 대마초 소비재 회사이자 소매업체가 2025년 5월 7일 시장 마감 후 첫 분기 실적 발표를 예정했습니다.
회사는 2025년 5월 8일 오전 8시 EDT에 재무 결과를 논의하기 위해 컨퍼런스 콜을 개최합니다. 투자자들은 마리메드의 투자자 관계 웹사이트를 통해 웹캐스트에 접속할 수 있으며, 통화 후에는 재생도 가능합니다.
MariMed (CSE: MRMD, OTCQX: MRMD), une entreprise leader dans le domaine des produits de consommation à base de cannabis et de la vente au détail, a prévu la publication de ses résultats financiers pour le premier trimestre 2025 pour le 7 mai 2025 après la fermeture du marché.
L'entreprise organisera une conférence téléphonique pour discuter des résultats financiers le 8 mai 2025 à 8h00 EDT. Les investisseurs peuvent accéder au webinaire via le site des Relations avec les Investisseurs de MariMed, où une rediffusion sera également disponible après l'appel.
MariMed (CSE: MRMD, OTCQX: MRMD), ein führendes Unternehmen für Cannabis-Verbrauchsgüter und Einzelhandel, hat die Veröffentlichung seiner Ergebnisse für das erste Quartal 2025 für den 7. Mai 2025 nach Marktschluss angesetzt.
Das Unternehmen wird am 8. Mai 2025 um 8:00 Uhr EDT eine Telefonkonferenz abhalten, um die finanziellen Ergebnisse zu besprechen. Investoren können über die Website der Investor Relations von MariMed auf das Webcast zugreifen, wo auch eine Wiedergabe nach dem Anruf verfügbar sein wird.
- None.
- None.
NORWOOD, Mass., April 08, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report first quarter 2025 financial results on May 7, 2025 after the markets close. Management will host a conference call on May 8, 2025 at 8:00 a.m. EDT to discuss financial results.
A webcast will be available and can be accessed via MariMed’s Investor Relations website at MariMed Q125 Earnings Webcast. A playback of the call will also be made available on MariMed’s Investor Relations website.
About MariMed
MariMed Inc. is a leading multi-state cannabis operator, known for developing and managing state-of-the-art cultivation, production, and retail facilities. Our award-winning portfolio of cannabis brands, including Betty's Eddies™, Bubby’s Baked™, InHouse™, Nature’s Heritage™, and Vibations™, sets us apart as an industry leader. These trusted brands, crafted with quality and innovation, are recognized and loved by consumers across the country. With a commitment to excellence, MariMed continues to drive growth and set new standards in the cannabis industry. For additional information, visit www.marimedinc.com.
Company Contact:
Howard Schacter
Chief Communications Officer
Email: hschacter@marimedinc.com
Phone: (781) 277-0007
FAQ
When will MariMed (MRMD) release its Q1 2025 earnings?
What time is MariMed's (MRMD) Q1 2025 earnings call?
How can investors access MariMed's (MRMD) Q1 2025 earnings call?
Will there be a replay available for MariMed's (MRMD) Q1 2025 earnings call?
